International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(1), С. 356 - 356
Опубликована: Янв. 3, 2025
Patients
with
mild
cognitive
impairment
due
to
Alzheimer’s
disease
(ADMCI)
typically
show
abnormally
high
delta
(<4
Hz)
and
low
alpha
(8–12
rhythms
measured
from
resting-state
eyes-closed
electroencephalographic
(rsEEG)
activity.
Here,
we
hypothesized
that
the
abnormalities
in
rsEEG
activity
may
be
greater
ADMCI
patients
than
those
MCI
not
AD
(noADMCI).
Furthermore,
they
associated
diagnostic
cerebrospinal
fluid
(CSF)
amyloid–tau
biomarkers
patients.
An
international
database
provided
clinical–demographic–rsEEG
datasets
for
cognitively
unimpaired
older
(Healthy;
N
=
45),
(N
70),
noADMCI
45)
participants.
The
spanned
individual
delta,
theta,
frequency
bands.
eLORETA
freeware
estimated
cortical
sources.
Posterior
source
activities
were
reduced
group
compared
only
Healthy
but
also
(p
<
0.001).
Negative
associations
between
CSF
phospho-tau
total
tau
levels
posterior
observed
0.001),
whereas
amyloid
beta
42
marginal.
These
results
suggest
neurophysiological
brain
neural
oscillatory
synchronization
mechanisms
regulating
arousal
vigilance
through
are
mainly
affected
by
tauopathy
Neuron,
Год журнала:
2023,
Номер
112(4), С. 676 - 686.e4
Опубликована: Дек. 13, 2023
In
early
Alzheimer's
disease
(AD)
β-amyloid
(Aβ)
deposits
throughout
association
cortex
and
tau
appears
in
the
entorhinal
(EC).
Why
these
initially
appear
disparate
locations
is
not
understood.
Using
task-based
fMRI
multimodal
PET
imaging,
we
assess
impact
of
local
AD
pathology
on
network-to-network
interactions.
We
show
that
pathologies
flip
interactions
between
default
mode
network
(DMN)
medial
temporal
lobe
(MTL)
from
inhibitory
to
excitatory.
The
DMN
hyperexcited
with
increasing
levels
Aβ,
which
drives
hyperexcitability
within
MTL
this
directed
hyperexcitation
by
predicts
rate
accumulation
EC.
Our
results
support
a
model
whereby
Aβ
induces
disruptions
excitatory-inhibitory
balance
DMN,
driving
MTL,
leading
accumulation.
propose
Aβ-induced
candidate
causal
route
remote
EC-tau
Background:
Estimates
of
‘brain-predicted
age’
quantify
apparent
brain
age
compared
to
normative
trajectories
neuroimaging
features.
The
gap
(BAG)
between
predicted
and
chronological
is
elevated
in
symptomatic
Alzheimer
disease
(AD)
but
has
not
been
well
explored
presymptomatic
AD.
Prior
studies
have
typically
modeled
BAG
with
structural
MRI,
more
recently
other
modalities,
including
functional
connectivity
(FC)
multimodal
explored.
Methods:
We
trained
three
models
predict
from
FC,
(S),
or
MRI
(S+FC)
390
amyloid-negative
cognitively
normal
(CN/A−)
participants
(18–89
years
old).
In
independent
samples
144
CN/A−,
154
CN/A+,
impaired
(CI;
CDR
>
0)
participants,
we
tested
relationships
AD
biomarkers
amyloid
tau,
as
a
global
cognitive
composite.
Results:
All
the
control
training
set,
model
outperforming
unimodal
models.
estimates
were
significantly
CI
controls.
FC-BAG
was
reduced
CN/A+
CN/A−.
only,
S-BAG
S+FC
associated
advanced
pathology
lower
performance.
Conclusions:
Both
are
participants.
However,
FC
also
capture
complementary
signals.
Specifically,
may
unique
biphasic
response
pathology,
while
pathological
progression
decline
stage.
A
age-prediction
improves
sensitivity
healthy
differences.
Funding:
This
work
supported
by
National
Institutes
Health
(P01-AG026276,
P01-
AG03991,
P30-AG066444,
5-R01-AG052550,
5-R01-AG057680,
1-R01-AG067505,
1S10RR022984-01A1,
U19-AG032438),
BrightFocus
Foundation
(A2022014F),
Alzheimer’s
Association
(SG-20-690363-DIAN).
Scientific Reports,
Год журнала:
2023,
Номер
13(1)
Опубликована: Май 7, 2023
An
early
disruption
of
neuronal
excitation-inhibition
(E-I)
balance
in
preclinical
animal
models
Alzheimer's
disease
(AD)
has
been
frequently
reported,
but
is
difficult
to
measure
directly
and
non-invasively
humans.
Here,
we
examined
known
novel
neurophysiological
measures
sensitive
E-I
patients
across
the
AD
continuum.
Resting-state
magnetoencephalography
(MEG)
data
86
amyloid-biomarker-confirmed
subjects
continuum
(17
diagnosed
with
subjective
cognitive
decline,
18
mild
impairment
(MCI)
51
dementia
due
probable
(AD
dementia)),
46
healthy
elderly
20
young
control
were
reconstructed
source-space.
was
investigated
by
detrended
fluctuation
analysis
(DFA),
a
functional
E/I
(fE/I)
algorithm,
aperiodic
exponent
power
spectrum.
We
found
disrupted
ratio
specifically,
lower
DFA,
shift
towards
higher
excitation,
fE/I
exponent.
Healthy
showed
ratios
(<
1.0)
than
reported
previous
literature,
not
explained
age
or
choice
an
arbitrary
threshold
parameter,
which
warrants
caution
interpretation
results.
Correlation
analyses
that
DFA
(E-I
imbalance)
(more
excitation)
associated
worse
score
patients.
In
contrast,
hippocampi
MCI
score.
This
MEG-study
imbalance,
likely
increased
dementia,
stage
To
accurately
determine
direction
balance,
validations
currently
used
markers
additional
vivo
are
required.
Neuropsychology Review,
Год журнала:
2023,
Номер
34(1), С. 338 - 361
Опубликована: Март 6, 2023
Abstract
Despite
the
numerous
pharmacological
interventions
targeting
dementia,
no
disease-modifying
therapy
is
available,
and
prognosis
remains
unfavorable.
A
promising
perspective
involves
tackling
high-frequency
gamma-band
(>
30
Hz)
oscillations
involved
in
hippocampal-mediated
memory
processes,
which
are
impaired
from
early
stages
of
typical
Alzheimer’s
Disease
(AD).
Particularly,
positive
effects
entrainment
on
mouse
models
AD
have
prompted
researchers
to
translate
such
findings
into
humans
using
transcranial
alternating
current
stimulation
(tACS),
a
methodology
that
allows
endogenous
cortical
frequency-specific
manner.
This
systematic
review
examines
state-of-the-art
use
gamma-tACS
Mild
Cognitive
Impairment
(MCI)
dementia
patients
shed
light
its
feasibility,
therapeutic
impact,
clinical
effectiveness.
search
two
databases
yielded
499
records
resulting
10
included
studies
total
273
patients.
The
results
were
arranged
single-session
multi-session
protocols.
Most
demonstrated
cognitive
improvement
following
gamma-tACS,
some
showed
neuropathological
markers,
suggesting
feasibility
these
anyhow
far
strong
evidence
available
for
models.
Nonetheless,
small
number
their
wide
variability
terms
aims,
parameters,
measures,
make
it
difficult
draw
firm
conclusions.
We
discuss
methodological
limitations
studies,
proposing
possible
solutions
future
avenues
improve
research
dementia.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring,
Год журнала:
2023,
Номер
15(3)
Опубликована: Июль 1, 2023
Accumulation
and
interaction
of
amyloid-beta
(Aβ)
tau
proteins
during
progression
Alzheimer's
disease
(AD)
are
shown
to
tilt
neuronal
circuits
away
from
balanced
excitation/inhibition
(E/I).
Current
available
techniques
for
noninvasive
interrogation
E/I
in
the
intact
human
brain,
example,
magnetic
resonance
spectroscopy
(MRS),
highly
restrictive
(i.e.,
limited
spatial
extent),
have
low
temporal
resolution
suffer
ability
distinguish
accurately
between
different
neurotransmitters
complicating
its
interpretation.
As
such,
these
methods
alone
offer
an
incomplete
explanation
E/I.
Recently,
aperiodic
component
neural
power
spectrum,
often
referred
literature
as
'1/f
slope',
has
been
described
a
promising
scalable
biomarker
that
can
track
disruptions
potentially
underlying
spectrum
clinical
conditions,
such
autism,
schizophrenia,
or
epilepsy,
well
developmental
changes
seen
aging.
Journal of Cellular and Molecular Medicine,
Год журнала:
2023,
Номер
28(2)
Опубликована: Окт. 17, 2023
Alzheimer's
disease
(AD)
is
a
heterogeneous
neurodegenerative
with
multifaceted
neuropathological
disorders.
AD
characterized
by
intracellular
accumulation
of
phosphorylated
tau
proteins
and
extracellular
deposition
amyloid
beta
(Aβ).
Various
protease
enzymes,
including
neprilysin
(NEP),
are
concerned
the
degradation
clearance
Aβ.
Indeed,
defective
neuronal
pathway
due
to
dysfunction
enzymes
might
be
possible
mechanism
for
Aβ
subsequent
progression
neuropathology.
NEP
one
most
imperative
metalloproteinase
involved
in
This
review
aimed
highlight
role
inhibitors
AD.
The
combination
sacubitril
valsartan
which
called
angiotensin
receptor
blocker
inhibitor
(ARNI)
may
produce
beneficial
deleterious
effects
on
increase
risk
inhibition
clearance,
brain
bradykinin
(BK)
natriuretic
peptides
(NPs),
augment
pathogenesis
These
verdicts
come
from
animal
model
studies,
though
they
not
applied
humans.
However,
clinical
studies
revealed
promising
safety
findings
regarding
use
ARNI.
Moreover,
increases
various
neuroprotective
inflammation,
glucose
homeostasis
nerve
conduction.
Also,
inhibit
dipeptidyl
peptidase
4
(DPP4)
expression,
ameliorating
insulin
glucagon-like
peptide
1
(GLP-1)
levels.
proposed
that
have
protective
effect
against
development
increasing
GLP-1,
neuropeptide
Y
(NPY)
substance
P,
BK.
Preclinical
recommended
this
regard.
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
121(23)
Опубликована: Май 30, 2024
A
balanced
excitation-inhibition
ratio
(E/I
ratio)
is
critical
for
healthy
brain
function.
Normative
development
of
cortex-wide
E/I
remains
unknown.
Here,
we
noninvasively
estimate
a
putative
marker
whole-cortex
by
fitting
large-scale
biophysically
plausible
circuit
model
to
resting-state
functional
MRI
(fMRI)
data.
We
first
confirm
that
our
generates
realistic
dynamics
in
the
Human
Connectome
Project.
Next,
show
estimated
sensitive
gamma-aminobutyric
acid
(GABA)
agonist
benzodiazepine
alprazolam
during
fMRI.
Alprazolam-induced
changes
are
spatially
consistent
with
positron
emission
tomography
measurement
receptor
density.
then
investigate
relationship
between
and
neurodevelopment.
find
declines
heterogeneously
across
cerebral
cortex
youth,
greatest
reduction
occurring
sensorimotor
systems
relative
association
systems.
Importantly,
among
children
same
chronological
age,
lower
(especially
cortex)
linked
better
cognitive
performance.
This
result
replicated
North
American
(8.2
23.0
y
old)
Asian
(7.2
7.9
cohorts,
suggesting
more
mature
indexes
improved
cognition
normative
development.
Overall,
findings
open
door
studying
how
disrupted
trajectories
may
lead
dysfunction
psychopathology
emerges
youth.